Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2015 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2015)
Representativeness of RELAX-AHF Clinical Trial Population in Acute Heart Failure
Teresa S. Wang et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Renal Hemodynamic Effects of Serelaxin in Patients With Chronic Heart Failure A Randomized, Placebo-Controlled Study
Adriaan A. Voors et al.
CIRCULATION-HEART FAILURE (2014)
A Reevaluation of the Costs of Heart Failure and Its Implications for Allocation of Health Resources in the United States
Jeff Voigt et al.
CLINICAL CARDIOLOGY (2014)
Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
Gerasimos Filippatos et al.
EUROPEAN HEART JOURNAL (2014)
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2014)
Decongestion in acute heart failure
Robert J. Mentz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin- mediated relaxation after in vivo serelaxin treatment
Maria Jelinic et al.
FASEB JOURNAL (2014)
Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
Chrishan S. Samuel et al.
HYPERTENSION (2014)
Effect of Serelaxin on Mode of Death in Acute Heart Failure Results From the RELAX-AHF Study
G. Michael Felker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin-2) Causes Rapid and Sustained Bradykinin-Mediated Vasorelaxation
Chen Huei Leo et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension
Jennifer M. Sasser et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Learning from recent trials and shaping the future of acute heart failure trials
Robert J. Mentz et al.
AMERICAN HEART JOURNAL (2013)
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
Marco Metra et al.
EUROPEAN HEART JOURNAL (2013)
Risk following hospitalization in stable chronic systolic heart failure
Putte Abrahamsson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Correlation With Outcomes
Marco Metra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Rehospitalization for Heart Failure Problems and Perspectives
Mihai Gheorghiade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration
Silvia Nistri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches
Katerina Koniari et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2012)
Maternal vasodilation in pregnancy: the emerging role of relaxin
Kirk P. Conrad
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Effects of Relaxin on Arterial Dilation, Remodeling, and Mechanical Properties
Kirk P. Conrad et al.
CURRENT HYPERTENSION REPORTS (2011)
Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric Oxide
Jonathan T. McGuane et al.
ENDOCRINOLOGY (2011)
Angiogenic Growth Factors Are New and Essential Players in the Sustained Relaxin Vasodilatory Pathway in Rodents and Humans
Jonathan T. McGuane et al.
HYPERTENSION (2011)
National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008
Jersey Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2010)
Cardiovascular effects of relaxin: from basic science to clinical therapy
Xiao-Jun Du et al.
NATURE REVIEWS CARDIOLOGY (2010)
Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
Thomas Dschietzig et al.
JOURNAL OF CARDIAC FAILURE (2009)
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R. Teerlink et al.
LANCET (2009)
Effect of relaxin on myocardial ischemia injury induced by isoproterenol
J Zhang et al.
PEPTIDES (2005)
Heart failure etiology and response to milrinone in decompensated heart failure - Results from the OPTIME-CHF study
GM Felker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist -: Attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-κB
T Dschietzig et al.
CIRCULATION RESEARCH (2003)
Share Paper
